Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Total Non-Current Liabilities (2016 - 2025)

Chemours (CC) has 12 years of Total Non-Current Liabilities data on record, last reported at $7.0 billion in Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 2.86% year-over-year to $7.0 billion; the TTM value through Dec 2025 reached $7.0 billion, up 2.86%, while the annual FY2025 figure was $7.0 billion, 2.86% up from the prior year.
  • Total Non-Current Liabilities reached $7.0 billion in Q4 2025 per CC's latest filing, down from $7.2 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $7.5 billion in Q4 2023 and bottomed at $6.0 billion in Q2 2022.
  • Average Total Non-Current Liabilities over 5 years is $6.6 billion, with a median of $6.5 billion recorded in 2021.
  • Peak YoY movement for Total Non-Current Liabilities: grew 15.34% in 2023, then dropped 8.15% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $6.4 billion in 2021, then rose by 0.84% to $6.5 billion in 2022, then rose by 15.34% to $7.5 billion in 2023, then dropped by 8.15% to $6.8 billion in 2024, then grew by 2.86% to $7.0 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $7.0 billion in Q4 2025, $7.2 billion in Q3 2025, and $7.1 billion in Q2 2025.